SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-059712
Filing Date
2019-12-09
Accepted
2019-12-09 16:58:23
Documents
1
Period of Report
2019-12-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5785
  Complete submission text file 0001209191-19-059712.txt   8436
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST. PAUL STREET BALTIMORE MD 21202 4102440115
NEA 12 GP, LLC (Reporting) CIK: 0001383389 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36485 | Film No.: 191275823

Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST. PAUL STREET BALTIMORE MD 21202 4102440115
NEA Partners 12, Limited Partnership (Reporting) CIK: 0001383390 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36485 | Film No.: 191275824

Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address 1119 ST. PAUL STREET BALTIMORE MD 21202 4102440115
New Enterprise Associates 12, Limited Partnership (Reporting) CIK: 0001383391 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36485 | Film No.: 191275825

Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences